AXIM® Biotech Expands Advisory Board to Broaden the Development of Cannabinoids' Therapeutic Indications NEW YORK, Dec. 29, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in biotechnology cannabinoid research and development, announced today the addition...

Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace to Advisory Board NEW YORK, Aug. 26, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce the latest appointment to its Board of Advisors: Mr. Joe Grace. A proven business and marketing...